High Frequency of Dysphoric Reactions to Tetrahydrocannabinol Among Depressed Patients
Abstract
This study reports a high incidence of dysphoric reactions to Δ9-tetrahydrocannabinol (THC) administered under double-blind conditions to a well-defined homogeneous population of hospitalized patients with unipolar depressive illness. Personality characteristics that might predispose patients to dysphoric reactions are examined and the implications of the effect of THC on the mood of depressed patients are discussed.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
